¿¬¼ö°­ÁÂ
Á¦4ȸ ½ÉºÎÀü¿Ü°úÇÐȸ & Á¦6ȸ DAHF JOINT SYMPOSIUM(1ÀÏÂ÷) : 2022-10-21
Á¦4ȸ ½ÉºÎÀü¿Ü°úÇÐȸ & Á¦6ȸ DAHF JOINT SYMPOSIUM(1ÀÏÂ÷) : 2022-10-21
±³À°ÀÏÀÚ : 2022-10-21
±³À°Àå¼Ò : ´ë±¸ ¼ö¼º½ºÄù¾î ÄÁº¥¼ÇȦ  
±³À°ÁÖÁ¦ : Á¦4ȸ ½ÉºÎÀü¿Ü°úÇÐȸ & Á¦6ȸ DAHF JOINT SYMPOSIUM(1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÈäºÎ¿Ü°úÇÐȸ(21.11.10 ¸íĪº¯°æ ´ëÇѽÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉºÎÀü¿Ü°úÇÐȸ  
´ã´çÀÚ : ¼ÕÁ¤¿ø
¿¬¶ôó : 02-365-7869  
À̸ÞÀÏ : society@ktcs.or.kr      
±³À°Á¾·ù : ÈäºÎ¿Ü°ú      
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 2Á¡  
Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 2 ½Ã°£ 25ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í Àü¹®ÀÇ: 5¸¸¿ø, / Àü°øÀÇ: 3¸¸¿ø, / ü¿Ü¼øȯ»ç,°£È£»ç,Çлý: 1¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-21 ´ë±¸ ¼ö¼º½ºÄù¾î ÄÁº¥¼ÇȦ 16:05~16:20 ExcorÀÇ º¸Çè ½ÂÀÎ ±âÁØ¿¡ ´ëÇÑ °³¼±Á¡  Á¶¼º±Ô(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10-21 ´ë±¸ ¼ö¼º½ºÄù¾î ÄÁº¥¼ÇȦ 16:20~16:35 À̽ÄÇü VADÀÇ º¸Çè ½ÂÀÎ ±âÁØ¿¡ ´ëÇÑ °³¼±Á¡  Á¤Àμ®(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 10-21 ´ë±¸ ¼ö¼º½ºÄù¾î ÄÁº¥¼ÇȦ 16:35~16:50 ½ÉÀåÀÌ½Ä ÀÀ±Þµµ °³Á¤ ¿ä±¸µµ¿Í °³¼±¾È  ÀÌÈñ¹®(ºÎõ¼¼Á¾) 
±³À°½Ã°£ 10-21 ´ë±¸ ¼ö¼º½ºÄù¾î ÄÁº¥¼ÇȦ 16:50~17:05 Organ care system µµÀÔÀÇ Çʿ伺  ½ÉÈƺ¸(ÀÌÈ­ÀÇ´ë) 
Åä·Ð 10-21 ´ë±¸ ¼ö¼º½ºÄù¾î ÄÁº¥¼ÇȦ 17:05~17:20 Panel discussion  () 
È޽Ġ10-21  17:20~17:30   () 
±³À°½Ã°£ 10-21 ´ë±¸ ¼ö¼º½ºÄù¾î ÄÁº¥¼ÇȦ 17:30~17:45 Sodium-glucose co-transporter 2 Inhibitors: Mechanism, Evidences, Practical Aspects  À̼±È­(°è¸íÀÇ´ë) 
±³À°½Ã°£ 10-21 ´ë±¸ ¼ö¼º½ºÄù¾î ÄÁº¥¼ÇȦ 17:45~17:55 Case 1 : Heart-Kidney co-transplantation  ¼Û°æ¼·(°è¸íÀÇ´ë) 
±³À°½Ã°£ 10-21 ´ë±¸ ¼ö¼º½ºÄù¾î ÄÁº¥¼ÇȦ 17:55~18:05 Case 2 : HeartMate3 through left thoracotomy to descending aorta  Á¶¾çÇö(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 10-21 ´ë±¸ ¼ö¼º½ºÄù¾î ÄÁº¥¼ÇȦ 18:05~18:15 Case 3 : Extracorporeal membrane oxygenation support for right ventricular failure after left ventricular assist device implantation  ±èÈ¿Çö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 10-21 ´ë±¸ ¼ö¼º½ºÄù¾î ÄÁº¥¼ÇȦ 18:15~18:25 Case 4 : The end of preoperative cardiorenal syndrome after LVAD implantation  ±è»óÀ±(ºÐ´ç¼­¿ï´ë) 
Åä·Ð 10-21 ´ë±¸ ¼ö¼º½ºÄù¾î ÄÁº¥¼ÇȦ 18:25~18:40 Panel discussion  () 
  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[¼­¿ï] (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­Á : 2024-03-09

±³À°ÀÏÀÚ : 2024-03-09 ±³À°Àå¼Ò : (¿Â¶óÀÎ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ½Å¼ººóÇ÷¿¬

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,657 , ´ñ±Û¼ö : 0

[¼­¿ï] Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialysis Vascular Access) : 2024-03-31

±³À°ÀÏÀÚ : 2024-03-31 ±³À°Àå¼Ò : °¡Å縯ÀÇ´ë ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ ±³À°ÁÖÁ¦ : Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialy

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,712 , ´ñ±Û¼ö : 0

[ºÎ»ê] 2024 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ãá°èÇмú´ëȸ : 2024-03-16

±³À°ÀÏÀÚ : 2024-03-16 ±³À°Àå¼Ò : ÇØ¿î´ë¹éº´¿ø 5Ãþ ´ë°­´ç ±³À°ÁÖÁ¦ : 2024 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑÄ¡¸ÅÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ»ê¿ï

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,708 , ´ñ±Û¼ö : 0

[¼­¿ï] ¼¼ºê¶õ½ºº´¿ø 2018 ¼¼¸ñȸ Çмú´ëȸ : 2018-11-10

±³À°ÀÏÀÚ : 2018-11-10 ±³À°Àå¼Ò : °­³² ¼¼ºê¶õ½ºº´¿ø ´ë°­´ç ±³À°ÁÖÁ¦ : 2018 ¼¼¸ñȸ Çмú´ëȸ ÁÖÃÖ±â°ü : ¼¼ºê¶õ½ºº´¿ø ½ÃÇà±â°ü(ÁöºÎ/°ú) : ¾È°ú ´ã´çÀÚ : ¹Ú

Ãßõ¼ö : 0 , Á¶È¸¼ö : 6,392 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇÑÁ¶Çöº´ÇÐȸ Treatment and management of symptoms and physical health in schizophrenia : 2024-04-2..

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ±³À°ÁÖÁ¦ : Treatment and management of symptoms and physical health i

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,398 , ´ñ±Û¼ö : 0